When protein destruction runs amok, malignancy is on the loose
Open Access
- 1 October 2003
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 4 (4) , 251-256
- https://doi.org/10.1016/s1535-6108(03)00243-5
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The proteasome: structure, function, and role in the cellPublished by Elsevier ,2003
- Inhibiting the p53–MDM2 interaction: an important target for cancer therapyNature Reviews Cancer, 2003
- Deregulated degradation of the cdk inhibitor p27 and malignant transformationSeminars in Cancer Biology, 2002
- Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapyThe EMBO Journal, 2002
- Gankyrin Is an Ankyrin-repeat Oncoprotein That Interacts with CDK4 Kinase and the S6 ATPase of the 26 S ProteasomeJournal of Biological Chemistry, 2002
- The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activityCurrent Opinion in Genetics & Development, 2002
- The Von Hippel—Lindau tumor suppressor complex and regulation of hypoxia-inducible transcriptionPublished by Elsevier ,2002
- Order from DestructionScience, 2001
- Translocations involving c-myc and c-myc functionOncogene, 2001
- Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathwayOncogene, 1997